Safety considerations of a new anti-CMV cellular therapy - experience from donor-derived, directly selected, adoptively transferred T cells (Cytovir (TM) CMV) in 2 randomized clinical trials
2015
Keywords:
-
Correction
-
Cite
-
Save
0
References
0
Citations
NaN
KQI